Results 231 to 240 of about 4,658,239 (268)

Biology of factor IX

Blood Coagulation & Fibrinolysis, 1992
Within the past 20 years or so, factor IX has been at the centre of particularly intensive studies of its physiology, pathology and biochemistry as well as its molecular genetics and biology. With the complete nucleotide sequence of its human gene determined in 1985 and the molecular defects of over 600 abnormal human factor IX genes analysed to date ...
K, Kurachi   +3 more
openaire   +3 more sources

Heterogeneity of factor IX in therapeutic factor IX concentrates

Thrombosis Research, 1978
Abstract Rabbit antibody to human factor IX was used to investigate the factor IX antigenic content and electrophoretic mobility of commercial products as well as experimental “activated products”. Rocket immunoelectrophoresis of all concentrates showed a 1.2–3 fold increased antigenic content/unit factor IX clotting activity when compared to plasma.
D, Menache, D L, Aronson
openaire   +2 more sources

Recombinant Factor IX

Thrombosis and Haemostasis, 1997
Despite the introduction of recombinant preparations of factor VIII and recombinant factor VII and VIIa, patients with other forms of hemophilia, especially hemophilia B, have remained at increased risk for blood borne viruses because of a lack of clinically utilizable preparations of recombinant factor IX.
G C, White, A, Beebe, B, Nielsen
openaire   +2 more sources

Heterogeneity of factor IX BM difference of cleavage sites by factor XIa and Ca2+in factor IX Kashihara, Factor IX Nagoya and Factor IX Niigata

Thrombosis Research, 1986
Abnormal factor IX was isolated from the plasma of a patient with hemophilia B Kashihara and two patients with hemophilia BM. The F.IX was purified to homogeneity by using monoclonal anti-F.IX-Sephrose, heparin-Sepharose and DEAE-Sephadex A-50 affinity chromatography successively.
A, Yoshioka   +7 more
openaire   +2 more sources

Standardization of Factor IX: Standards for "Purified" Factor IX Concentrates

Thrombosis and Haemostasis, 1991
SummaryAn international collaborative study was carried out to determine the suitability of the current WHO II-IX-X concentrate standard, 84/681, for assigning potency to the more highly purified factor IX concentrates. Three Coagulation Factor IX (Human) preparations and one Factor IX Complex preparation were assayed by the one stage method against ...
M A, Lamb, W A, Fricke, S C, Rastogi
openaire   +2 more sources

Factor IX and thrombosis

Scandinavian Journal of Haematology, 1977
Fractionation technology has made Factor IX concentrates available. In addition to a very high incidence of hepatitis, thrombosis is being recognized as a consequence of their use. Contradictory reports exist in the literature as to the incidence of thrombotic events.
openaire   +2 more sources

Home - About - Disclaimer - Privacy